These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2874569)

  • 1. Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats.
    Hara C; Kastin AJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1785-7. PubMed ID: 2874569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse.
    Mycroft FJ; Wei ET
    Peptides; 1984; 5(5):883-7. PubMed ID: 6150468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
    Kostrzewa RM; Kastin AJ
    Brain Res Bull; 1993; 31(6):707-12. PubMed ID: 8100182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide.
    Mycroft FJ; Bhargava HN; Wei ET
    Peptides; 1987; 8(6):1051-5. PubMed ID: 2894644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the rat.
    Bhargava HN
    Life Sci; 1981 Jul; 29(1):45-51. PubMed ID: 6115301
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    Neuropharmacology; 1982 Sep; 21(9):917-22. PubMed ID: 6128692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs.
    Kastin AJ; Abel DA; Ehrensing RH; Coy DH; Graf MV
    Pharmacol Biochem Behav; 1984 Nov; 21(5):767-71. PubMed ID: 6151196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats.
    Hara C; Kastin AJ
    Pharmacol Biochem Behav; 1986 Oct; 25(4):757-61. PubMed ID: 2878442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor antagonists block the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK
    Neuropeptides; 1991 Aug; 19(4):281-5. PubMed ID: 1681456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of brain dopamine receptors antagonizes the anti-immobility effect of MIF-1 and Tyr-MIF-1 in rats.
    Pulvirenti L; Kastin AJ
    Eur J Pharmacol; 1988 Jul; 151(2):289-92. PubMed ID: 2901971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyr-MIF-1 affects passive avoidance behavior but not motor activity in rats.
    Hayashi T; Kastin AJ; Coy DH; Olson RD
    Brain Res Bull; 1983 Dec; 11(6):659-62. PubMed ID: 6140994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some analogs of Tyr-MIF-1 affect passive avoidance behavior but not motor activity in rats.
    Hayashi T; Fischman AJ; Kastin AJ; Coy DH
    Pharmacol Biochem Behav; 1984 Nov; 21(5):809-12. PubMed ID: 6151198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on GH, LH, prolactin, FSH, and TSH secretion in rats with and without morphine.
    Krowicki ZK; Kastin AJ
    Neuropeptides; 1991 Jan; 18(1):41-7. PubMed ID: 1675454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides.
    Pan W; Kastin AJ
    Peptides; 2007 Dec; 28(12):2411-34. PubMed ID: 17988762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products.
    Horowitz D; Callahan JF; Pelus LM; Fukuda S; King AG
    Int Immunopharmacol; 2002 Apr; 2(5):721-30. PubMed ID: 12013510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.
    Björkman S; Castensson S; Sievertsson H
    J Med Chem; 1979 Aug; 22(8):931-5. PubMed ID: 40028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central administration of Tyr-MIF-1 stimulates gastrointestinal motility in rats: evidence for the involvement of dopamine, sigma and CCK receptors.
    Million M; Fioramonti J; Bueno L
    Neuropeptides; 1994 Feb; 26(2):77-85. PubMed ID: 7909585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.